DDL-218 is an orally active and potent SirT1 inhibitor. DDL-218 enhances SirT1 in ApoE4-expressing neurons and a murine AD model. DDL-218 can be used in the study of Alzheimers disease[1].
Molecular Weight:
222.28
Purity:
99.49
CAS Number:
[2767324-34-3]
Formula:
C12H18N2O2
Target:
Sirtuin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted